Kwartaalbericht 4e kwartaalNovember 2005 Contents

First Page		Document Content
Alcohols Organochlorides Organofluorides Sulfonamides Bosentan Venlafaxine Pulmonary hypertension Sitaxentan Endothelin receptor antagonist Chemistry Organic chemistry Selective serotonin reuptake inhibitors		Kwartaalbericht 4e kwartaalNovember 2005 Contents Add to Reading List Source URL: www.lareb.nl Download Document from Source Website File Size: 297,28 KB Share Document on Facebook

	Clinical Commissioning Policy: Clinical Commissioning Policy: National policy for targeted DocID: 18zFu - View Document
	Kwartaalbericht 4e kwartaalNovember 2005 Contents DocID: 15SVk - View Document
	ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. DocID: 15iVb - View Document
	Better understanding of blood vessel constrictor needed to harness its power for patients DocID: RsPy - View Document
	Bosentan (Tracleer®) Issued by PHA’s Scientific Leadership Council Information is based on the United States Food and Drug Administration drug labeling Last Updated November[removed]WHAT IS BOSENTAN? DocID: QGSp - View Document